PipelineReview.com3 小时
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of ...
PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...